Literature DB >> 7951676

Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein.

C R Harrington1, R H Perry, E K Perry, J Hurt, I G McKeith, M Roth, C M Wischik.   

Abstract

We have used biochemical assays to examine cingulate and occipital cortices from age-matched cases of Alzheimer's disease (AD; n = 12), senile dementia of the Lewy body type (SDLT; n = 13), Parkinson's disease (PD; 5 non-demented cases and 7 cognitively impaired cases) and controls (n = 11) for paired helical filaments (PHFs), phosphorylated and normal tau protein and beta/A4-protein. Whereas cingulate cortex is characterised by relatively high densities of cortical Lewy bodies in the SDLT cases and lower numbers in PD, these inclusion bodies were absent in the cingulate cortex from AD and control cases. Protease-resistant PHFs and hyperphosphorylated tau protein were found in AD and, at low levels, in a minority of SDLT cases. Qualitatively, both of these preparations were indistinguishable in SDLT from those found in AD but levels of both parameters in SDLT were less than 5% of those in AD. SDLT, PD and control groups did not differ from each other in terms of the quantity of protease-resistant PHFs or the level of hyperphosphorylated tau. Furthermore, PHF accumulation did not distinguish between PD cases with or without dementia. The levels of normal tau protein did not differ between the four groups. beta/A4 protein levels did not distinguish between PD and control groups, between AD and SDLT groups, or between SDLT and control groups for either cingulate or occipital cortices. Thus extensive accumulation of PHFs in either neurofibrillary tangles or dystrophic neurites is not a feature of either SDLT or PD. Our findings provide molecular support for the neuropathological and clinical separation of SDLT as a form of dementia that is distinct from AD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7951676     DOI: 10.1159/000106727

Source DB:  PubMed          Journal:  Dementia        ISSN: 1013-7424


  11 in total

1.  Both total and phosphorylated tau are increased in Alzheimer's disease.

Authors:  M Sjögren; P Davidsson; M Tullberg; L Minthon; A Wallin; C Wikkelso; A K Granérus; H Vanderstichele; E Vanmechelen; K Blennow
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-05       Impact factor: 10.154

2.  Difficulty processing temporary syntactic ambiguities in Lewy body spectrum disorder.

Authors:  Murray Grossman; Rachel G Gross; Peachie Moore; Michael Dreyfuss; Corey T McMillan; Philip A Cook; Sherry Ash; Andrew Siderowf
Journal:  Brain Lang       Date:  2011-09-29       Impact factor: 2.381

3.  The organization and anatomy of narrative comprehension and expression in Lewy body spectrum disorders.

Authors:  Sharon Ash; Sharon X Xie; Rachel Goldmann Gross; Michael Dreyfuss; Ashley Boller; Emily Camp; Brianna Morgan; Jessica O'Shea; Murray Grossman
Journal:  Neuropsychology       Date:  2012-02-06       Impact factor: 3.295

4.  The organization of narrative discourse in Lewy body spectrum disorder.

Authors:  Sharon Ash; Corey McMillan; Rachel G Gross; Philip Cook; Brianna Morgan; Ashley Boller; Michael Dreyfuss; Andrew Siderowf; Murray Grossman
Journal:  Brain Lang       Date:  2011-10       Impact factor: 2.381

5.  Frequency of the apolipoprotein E epsilon 4 allele in a case-control study of early onset Parkinson's disease.

Authors:  A S Whitehead; S Bertrandy; F Finnan; A Butler; G D Smith; Y Ben-Shlomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

6.  Impairments of speech fluency in Lewy body spectrum disorder.

Authors:  Sharon Ash; Corey McMillan; Rachel G Gross; Philip Cook; Delani Gunawardena; Brianna Morgan; Ashley Boller; Andrew Siderowf; Murray Grossman
Journal:  Brain Lang       Date:  2011-11-17       Impact factor: 2.381

7.  Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.

Authors:  C R Harrington; J Louwagie; R Rossau; E Vanmechelen; R H Perry; E K Perry; J H Xuereb; M Roth; C M Wischik
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

8.  Verbal learning and memory in patients with dementia with Lewy bodies or Parkinson's disease with dementia.

Authors:  J Vincent Filoteo; David P Salmon; Dawn M Schiehser; Amy E Kane; Joanne M Hamilton; Laurie M Rilling; John A Lucas; Vanessa Zizak; Douglas R Galasko
Journal:  J Clin Exp Neuropsychol       Date:  2009-02-17       Impact factor: 2.475

9.  Parkin promotes intracellular Abeta1-42 clearance.

Authors:  Mark P Burns; Lihua Zhang; G William Rebeck; Henry W Querfurth; Charbel E-H Moussa
Journal:  Hum Mol Genet       Date:  2009-05-29       Impact factor: 6.150

10.  Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5.

Authors:  J P Brion; A M Couck
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.